Approaches to accelerating the study of new antiretrovirals in pregnancy

INTRODUCTION: Women who are pregnant or who could become pregnant experience delayed access to or underinformed use of important new antiretroviral (ARV) drugs because of traditional drug development processes that ostensibly aim to reduce potential harm but effectively fail to ensure that timely in...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrams, Elaine J., Calmy, Alexandra, Fairlie, Lee, Mahaka, Imelda C., Chimula, Lameck, Flynn, Patricia M., Kinuthia, John, Myer, Landon, Khoo, Saye H., Musoke, Philippa, Zwerski, Sheryl, Zech, Jennifer M., Lockman, Shahin, Siberry, George K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294864/
https://www.ncbi.nlm.nih.gov/pubmed/35851757
http://dx.doi.org/10.1002/jia2.25916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294864/
https://www.ncbi.nlm.nih.gov/pubmed/35851757
http://dx.doi.org/10.1002/jia2.25916

Ejemplares similares